Waldron Private Wealth’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Waldron Private Wealth's EW Position: Q3 2024 in Review
Waldron Private Wealth sold out of Edwards Lifesciences (EW) in Q3 2024, closing a stake of 2,946 shares — an estimated $272K sold.
Waldron Private Wealth first reported a position in EW in Q4 2019 and held it in 17 quarters. The position peaked at $475K in Q4 2021. 1,194 funds tracked by Wall St. Rank hold EW as of Q3 2024.
- Waldron Private Wealth reported no remaining Edwards Lifesciences position as of Q3 2024 after selling out during the quarter.
- Waldron Private Wealth sold 2,946 Edwards Lifesciences shares in Q3 2024, an estimated $272K.
- Waldron Private Wealth first reported a position in Edwards Lifesciences in Q4 2019 and held it in 17 quarters.
- Waldron Private Wealth's Edwards Lifesciences position peaked at $475K in Q4 2021.
- 1,194 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2024.
Based on Waldron Private Wealth's 13F filing for Q3 2024, filed 21 Oct 2024.